Bluejay Diagnostics Inc (BJDX) — Cash Flow-to-Debt Ratio
Bluejay Diagnostics Inc (BJDX) has a Cash Flow-to-Debt Ratio of -1.12x as of March 2026, meaning its operating cash flow of $-1.59 Million could theoretically repay -1% of its total liabilities ($1.42 Million) in one year. See BJDX working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bluejay Diagnostics Inc Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Bluejay Diagnostics Inc across 7 annual periods. Also explore Bluejay Diagnostics Inc (BJDX) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bluejay Diagnostics Inc (2019–2025)
Year-by-year debt coverage analysis for Bluejay Diagnostics Inc. For market capitalisation and broader financial context, see Bluejay Diagnostics Inc (BJDX) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.29x | $-6.05 Million | $1.14 Million | ▲ +37.2% |
| 2024 | -8.43x | $-7.82 Million | $927.92K | ▼ -100.1% |
| 2023 | -4.21x | $-8.31 Million | $1.97 Million | ▼ -7.7% |
| 2022 | -3.91x | $-7.74 Million | $1.98 Million | ▲ +42.9% |
| 2021 | -6.85x | $-4.37 Million | $637.16K | ▼ -7610.8% |
| 2020 | -0.09x | $-508.71K | $5.72 Million | ▲ +79.8% |
| 2019 | -0.44x | $-1.69 Million | $3.85 Million | — |